Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flows from operating activities:    
Net income (loss) $ 204,090 $ (278,034)
Adjustment to reconcile net income to net cash provided by operating activities:    
Depletion, depreciation, amortization, and accretion 159,447 65,360
Impairment of unproved properties 9,564 4,019
Commodity derivative fair value gains (285,510) (52,210)
Cash receipts for settled derivatives 109,311 141,506
Gain on sale of assets   (291,190)
Loss (gain) on sale of discontinued operations (5,000) 427,232
Deferred income tax expense 120,695 87,695
Depletion, depreciation, amortization, accretion, and impairment of unproved properties - discontinued operations   78,616
Commodity derivative fair value gains - discontinued operations   (46,358)
Cash receipts for settled derivatives - discontinued operations   79,736
Deferred income tax expense - discontinued operations 1,900 4,085
Other 3,911 (4,567)
Changes in current assets and liabilities:    
Accounts receivable (11,727) (16,811)
Accrued revenue (39,453) 17,378
Other current assets 1,702 (3,112)
Accounts payable (4,602) (9,812)
Accrued liabilities 44,720 7,281
Revenue distributions payable 22,889 (414)
Other   15,000
Net cash provided by operating activities 331,937 225,400
Cash flows from investing activities:    
Additions to proved properties   (4,451)
Additions to unproved properties (342,832) (428,574)
Development costs (1,267,086) (619,344)
Additions to gathering systems and facilities (240,119) (58,748)
Additions to other property and equipment (3,225) (2,786)
Proceeds from asset sales   816,167
Changes in other assets (11,622) 2,556
Net cash used in investing activities (1,864,884) (295,180)
Cash flows from financing activities:    
Issuance of senior notes 231,750  
Borrowings on bank credit facility, net 1,295,500 82,000
Payments of deferred financing costs (8,334)  
Other 6,626 992
Net cash provided by financing activities 1,525,542 82,992
Net increase (decrease) in cash and cash equivalents (7,405) 13,212
Cash and cash equivalents, beginning of period 18,989 3,343
Cash and cash equivalents, end of period 11,584 16,555
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest (70,221) (61,930)
Supplemental disclosure of noncash investing activities:    
Increase in accounts payable for additions to properties, gathering systems, and facilities $ 134,525 $ 73,430